Biblio

Author Title [ Type

] Year

Filters: Author is Wang, Nan [Clear All Filters]

Journal Article

Wang N, Ma J-M. Progress of Cancer Stem Cells in Retinoblastoma. Curr Stem Cell Res Ther. 2023.

Wang N, Wang L, Yang J, Wang Z, Cheng L. Quercetin promotes osteogenic differentiation and antioxidant responses of mouse bone mesenchymal stem cells through activation of the AMPK/SIRT1 signaling pathway. Phytother Res. 2021.

Chu R, Wang N, Bi Y, Nan G. Rapamycin prevents lung injury related to acute spinal cord injury in rats. Sci Rep. 2023;13(1):10674.

Chen M, Wang N, Yang H, Liu D, Gao Y, Duo L, Cui X, Hao F, Ye J, Gao F, et al. Single-cell transcriptome analysis of the germ cells and somatic cells during mitotic quiescence stage in goats. FASEB J. 2023;37(11):e23244.

Shi X, Xiao Z, Zonta F, Wang W, Wan Y, Li Y, Wang N, Kuang Y, Du M, Dong J, et al. Somatic MIWI2 Hinders Direct Lineage Reprogramming from Fibroblast to Hepatocyte. Stem Cells. 2019.

Ashley RJ, Yan H, Wang N, Hale J, Dulmovits BM, Papoin J, Olive ME, Udeshi ND, Carr SA, Vlachos A, et al. Steroid-resistance in Diamond Blackfan anemia associates with p57Kip2 dysregulation in erythroid progenitors. J Clin Invest. 2020.

Hang S, Wang N, Sugimura R. T, NK, then macrophages: Recent advances and challenges in adaptive immunotherapy from human pluripotent stem cells. Differentiation. 2023;130:51-57.

Wang H, Wang N, Wang L, Du J, Li F, Shao Y, Peng B, Luan S, Wang L, Jin X, et al. Targeted dosing of anti-thymocyte globulin in adult unmanipulated haploidentical peripheral blood stem cell transplantation: A single-arm, phase 2 trial. Am J Hematol. 2023.

Wang N, Yin J, You N, Zhu W, Guo N, Liu X, Zhang P, Huang W, Xie Y, Ren Q, et al. Twist family BHLH transcription factor 1 is required for the maintenance of leukemia stem cell in MLL-AF9+ acute myeloid leukemia. Haematologica. 2023.

Wang N, Guo D, Zhao YY, Dong CY, Liu X, Yang BX, Wang SW, Wang L, Liu QG, Ren Q, et al. TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia. Oncotarget. 2015.

Wang D, Du G, Chen X, Wang J, Liu K, Zhao H, Cheng C, He Y, Jing N, Xu P, et al. Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer. Cell Death Differ. 2024.

Pages